Healthy Aging FDA Approves Yuvezzi: First Dual-Action Eye Drop to Eliminate Reading Glasses February 05, 2026
Mental health FDA Approves Flow FL-100: Breaking Down the First At-Home Depression Headset February 01, 2026
Mental health FDA Clears ProlivRx: A Historic Shift in At-Home Depression Treatment February 01, 2026
Healthy Aging FDA Approves Yuvezzi: The First Dual-Agent Eye Drop to Reverse Age-Related Vision Loss January 31, 2026
Mental health FDA Approves First At-Home Depression Headset: Flow FL-100 Launches Q2 2026 January 31, 2026
